Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Headache|March 15, 2021
Quantitative arterial spin labeling magnetic resonance imaging analysis of reversible cerebral vasoconstriction syndrome: A case seriesYuya Kano, Shohei Inui, Yuto Uchida, et al.
Expert Opinion on Drug Safety|January 4, 2021
A long-term open-label safety study of galcanezumab in Japanese patients with migraineKoichi Hirata, Takao Takeshima, Fumihiko Sakai, et al.
Neurology and Therapy|September 12, 2023
Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled AnalysisShigekazu Kitamura, Takao Takeshima, Daishi Yui, et al.
The Journal of Headache and Pain|September 19, 2021
Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trialKoichi Hirata, Fumihiko Sakai, Takao Takeshima, et al.
Neurology and Therapy|September 29, 2024
A Discrete-Choice Experiment Assessing the Patient Preferences and Real-World Experiences of Patients with Migraine in JapanTakao Takeshima, Akira Yuasa, Yukie Michelle Lloyd, et al.
Cephalalgia : an International Journal of Headache|April 19, 2023
Developing an artificial intelligence-based headache diagnostic model and its utility for non-specialists' diagnostic accuracyMasahito Katsuki, Tomokazu Shimazu, Shoji Kikui, et al.
Neurobiology of Aging|May 5, 2004
A haplotype of the methylenetetrahydrofolate reductase gene is protective against late-onset Alzheimer's diseaseYosuke Wakutani, Hisanori Kowa, Masayoshi Kusumi, et al.
BMJ Open|August 19, 2023
Long-term efficacy and safety of erenumab in Japanese patients with episodic and chronic migraine: results from a 28-week open-label treatment period of a randomised trialKoichi Hirata, Takao Takeshima, Fumihiko Sakai, et al.
Cephalalgia : an International Journal of Headache|September 26, 2025
Atogepant for the preventive treatment of episodic migraine in Japanese participants: A phase 2/3, randomized, double-blind, placebo-controlled trial with an active treatment extension (RELEASE)Yasuhiko Matsumori, Hiroshi Yamada, Yoshishige Nagaseki, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 26, 2003
Non-linear dynamics applied to human respiratory movement during sleepNaoto Burioka, Hisashi Suyama, Takanori Sako, et al.
Pageof 14